Interpace Biosciences Inc Цена / балансовая стоимость
Что обозначает Цена / балансовая стоимость в Interpace Biosciences Inc?
Цена / балансовая стоимость Interpace Biosciences Inc является -0.07
Какое определение для Цена / балансовая стоимость?
Отношение рыночной цены акции к её балансовой учётной стоимости представляет собой соотношение между стоимостью акций компании и балансовой стоимостью на акцию.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Цена / балансовая стоимость компаний в Health Care сектор на NASDAQ по сравнению с Interpace Biosciences Inc
Что делает Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Компании с цена / балансовая стоимость похож на Interpace Biosciences Inc
- China Rundong Auto имеет Цена / балансовая стоимость из -0.07
- Uttam Value Steels имеет Цена / балансовая стоимость из -0.07
- Ferrellgas Partners имеет Цена / балансовая стоимость из -0.07
- Wheeler Real Estate Investment Trust Inc имеет Цена / балансовая стоимость из -0.07
- ION Geophysical Corp имеет Цена / балансовая стоимость из -0.07
- Invigor имеет Цена / балансовая стоимость из -0.07
- Interpace Biosciences Inc имеет Цена / балансовая стоимость из -0.07
- Federal National Mortgage Association имеет Цена / балансовая стоимость из -0.07
- Premier имеет Цена / балансовая стоимость из -0.07
- Bombay Rayon Fashions имеет Цена / балансовая стоимость из -0.07
- Supreme Infrastructure India имеет Цена / балансовая стоимость из -0.07
- AI Technology имеет Цена / балансовая стоимость из -0.07
- Sparta Commercial Services имеет Цена / балансовая стоимость из -0.07